ALXN Alexion Pharmaceuticals beats by $0.11, beats on revenue Alexion Pharmaceuticals (NASDAQ:ALXN): Q3 EPS of $1.27 beats by $0.11. Revenue of $555.15M (+38.6% Y/Y) beats by $13.22M. Shares -0.17% PM.